Relationship between ERCC1 expression and cisplatin intervention in human lung adenocarcinoma cell lines

Chinese Journal of Lung Cancer

Volumn 10, Issue 5, 2007, Pages 362-365

  Xia, Ying ^a   Hu, Chengping ^b   Zhang, Meichun ^b   Yang, Huaping ^b   Zhou, Dongbo ^b   Liang, Shuo ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NONE

Author keywords

Cisplatin; Drug resistance; ERCC1 gene; Lung neoplasms

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MESSENGER RNA;

ARTICLE; CANCER RESISTANCE; CELL ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; PROTEIN CONTENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 35948994140     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Xing CP, Liu B, Dong L. Judging criteria of immunohistochemical staining results. Chin J Pathol,2001,30(4) : 318.
2. Rosell R, Felip E, Taron M, et al. Gene expression as a predictive marker of outcome in stage II B- III A- III B non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. Clin Cancer Res,2004,10(12 Pt 2) : 4215S-4219S.
3. Ferry KV, Hamilton TC, Johnson SW. Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. Biochem Pharmacol,2000,60(9) : 1305-1313.
4. Li Q, Yu JJ, Mu C, et al. Association between the level of ERCC1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Anticancer Res,2000,20(2A) : 645-652.
5. Chen J, Bai CX, Qian GS. The establishment of multi-drug resistant cell lines A549/DDP. Chin Oncol,2003,13(2) : 186-187.
6. Lan L, Hayashi T, Rabeya RM, et al. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis- diamminedichloroplatinum(II) in mammalian cells. DNA Repair (Amst),2004,3(2) : 135-143.